| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Operating Officer | SVP, Chief Business Officer
1 company
Dahan Michel serves as a SVP, Chief Operating Officer at AKBA. Across recent SEC filings that breaks down to 0 buys and 25 sells. Those positions are worth an estimated $847K at current prices.
Historically, Dahan Michel's trades have earned a middling insider score of 59/100 across 10 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -4.8%.
The biggest single holding is AKBA (~$847K) as SVP, Chief Operating Officer. The recent filings there lean toward selling, a net 244,519 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2024 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Operating Officer | Sell10b5-1 | 34,840 | $1.26 | $43,898.40 | -4.9% | -4.7% | +92.2% | |
| Feb 29, 2024 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Operating Officer | Sell | 8,661 | $1.58 | $13,684.38 | -1.2% | -34.8% | +17.1% | |
| Feb 27, 2024 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Operating Officer | Sell | 10,744 | $1.52 | $16,330.88 | -1.5% | -34.8% | +9.8% | |
| May 25, 2023 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Operating Officer | Sell | 95,478 | $1.22 | $116,760.05 | -14.3% | +6.6% | -9.1% | |
| Mar 1, 2023 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Operating Officer | Sell | 20,412 | $0.88 | $17,911.53 | -7.0% | +4.8% | +72.7% | |
| Feb 27, 2023 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Operating Officer | Sell | 10,090 | $0.81 | $8,205.19 | -3.4% | +17.5% | +101.1% | |
| Mar 1, 2022 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Operating Officer | Sell | 21,533 | $2.17 | $46,637.46 | -6.8% | -82.8% | -57.4% | |
| Apr 1, 2021 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Operating Officer | Sell | 1,211 | $3.40 | $4,117.40 | -0.5% | +13.8% | -79.9% | |
| Mar 1, 2021 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Operating Officer | Sell | 14,547 | $3.40 | $49,403.07 | -5.4% | +1.3% | -36.1% | |
| Feb 28, 2020 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Operating Officer | Sell | 6,972 | $8.70 | $60,656.40 | -3.3% | - | - |